Related Experiment Video
Updated: Oct 19, 2025

10:27
In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
1.7K
CSCD2: an integrated interactional database of cancer-specific circular RNAs
Jing Feng1, Wenbo Chen2, Xin Dong2
1School of Computer Science, Wuhan University, Wuhan430072, China.
Nucleic Acids Research
|September 22, 2021
Summary
The updated Cancer-Specific CircRNA Database (CSCD2) now offers a comprehensive resource for cancer circRNA research. It identifies numerous cancer-specific circRNAs and predicts interactions with microRNAs and RNA-binding proteins.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Circular RNAs (circRNAs) play a significant role in cancer development.
- A centralized resource is needed to characterize circRNA interactions in cancer.
- The previous Cancer-Specific CircRNA Database (CSCD) was a valuable tool for circRNA research.
Purpose of the Study:
- To update and expand the CSCD database with more comprehensive circRNA data.
- To provide an enhanced resource for studying circRNA function and regulation in cancer.
- To predict interactions between circRNAs, microRNAs, and RNA-binding proteins.
Main Methods:
- Expanded data collection from over 1000 human cancer and normal tissue/cell line samples.
- Identification and cataloging of cancer-specific circRNAs, normal-specific circRNAs, and common circRNAs.
- Prediction of microRNA-circRNA and RNA-binding protein-circRNA interactions using binding motif analysis.
- Prediction of potential full-length and open reading frame sequences for circRNAs.
Main Results:
- CSCD2 includes 1,013,461 cancer-specific circRNAs, 1,533,704 normal-specific circRNAs, and 354,422 common circRNAs.
- The database incorporates data from 825 tissues and 288 cell lines.
- Predicted interactions involve over 200 RNA-binding proteins and 2000 microRNAs.
Conclusions:
- CSCD2 represents a significantly enhanced resource for cancer circRNA research.
- The database facilitates exploration of circRNA functions and regulatory mechanisms in cancer.
- CSCD2 supports the investigation of circRNA roles in oncogenesis and potential therapeutic strategies.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Rous Sarcoma Virus (RSV) and Cancer
5.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.6K
lncRNA - Long Non-coding RNAs
9.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.1K
RNA-seq
10.6K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.6K
Non-LTR Retrotransposons
12.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.1K
Cancer-Critical Genes I: Proto-oncogenes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K

